Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News

May & Baker targets N50 billion turnover by 2023

Damilare Famuyiwa by Damilare Famuyiwa
October 31, 2018
in Business News, Company News
EIB provides €50 million support for African pharmaceutical products, Chemical medicine - drugs
Share on FacebookShare on TwitterShare on Linkedin

The Chief Executive Officer (CEO) of Pharmaceutical company, May & Baker, Nnamdi Okafor has disclosed that the company is targetting a turnover of N50 billion by 2023.

Okorafor made this disclosure barely a week after May & Baker commenced rights issue of N2.45 billion in a bid to raise new capital.

While revealing the company’s target, Okorafor said the company is also committed to expanding its paracetamol production capacity. According to him, some of the proceeds from May & Baker’s rights issue would be used to build a plant.

RelatedPosts

Nigeria’s Securities and Exchange Commission warns against unregistered crowdfunding platforms

Nigeria’s Securities and Exchange Commission, AfDB sign $460K capital market surveillance deal

“Over N400 million of the expected N2.45 billion will be used to finance part of our equity in Biovaccines Nigeria Limited, the joint venture company for local vaccine production.

“We are also going to invest over N500 million on capacity expansion for one of our cash cow products, paracetamol, for which we are building a dedicated plant.

“Marketing and brand building is expected to take over N500 million. About N400 million will be used to offset part of its current loan portfolio of about N950 million, while the remaining will be used to buy working capital.” – Okafor

May & Baker Nigeria Plc’s rights issue opened on Monday, October 22, and would close on Wednesday, November 28, 2018. The company is planning to raise the new capital through new equity funds from existing shareholders.

Nairametrics reported that the company is offering 980 million ordinary shares of 50 kobo each at N2.50 per share to existing shareholders. The rights issue has been provisionally pre-allotted on the basis of one new ordinary share for every one ordinary share held as at the close of business on Tuesday, September 4, 2018.

News continues after this ad


The opening of the application followed the approval of the rights issue by the Securities and Exchange Commission (SEC) and the Nigerian Stock Exchange (NSE).

Capital Assets Limited and Compass Investments & Securities Limited are the stockbrokers to the rights issue, while Cordros Capital Limited and Afrinvest (West Africa) Limited are the issuing houses.

Related

Tags: May & BakerNnamdi OkaforNSESEC

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

inq
avatrade
Stanbic bank
Mega Millions
UBN
Hot forex
Access Bank
Bankers Committee
First bank






    Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

    Recent News

    • OPEC says Nigeria’s oil production averaged 1.183mbpd in July 2022
    • NAICOM approves appointment of Valentina Marinho as Non-executive director of Linkage Assurance
    • Universities in Australia offering scholarships to international students

    Follow us on social media:

    Recent News

    Latest drop in India’s oil import spells bad news for Nigeria’s forex reserves

    OPEC says Nigeria’s oil production averaged 1.183mbpd in July 2022

    August 11, 2022
    NAICOM

    NAICOM approves appointment of Valentina Marinho as Non-executive director of Linkage Assurance

    August 11, 2022
    • ABOUT US
    • CONTACT US
    • PRODUCTS
    • ANDROID APP
    • iOS APP
    • DISCLAIMER
    • CAREERS
    • PRIVACY POLICY

    © 2022 Nairametrics

    No Result
    View All Result
    • Home
    • Exclusives
      • Financial Analysis
      • Corporate Stories
      • Interviews
      • Investigations
      • Metrics
    • Markets
      • Cryptos
      • Commodities
      • Equities
        • Dividends
        • Stock Market
      • Fixed Income
      • Market Views
      • Securities
    • Industries
      • Company News
      • Consumer Goods
      • Content Partners
      • Corporate deals
      • Corporate Press Releases
      • Energy
      • Entertainment
      • Financial Services
      • Hospitality & Travel
      • Manufacturing
      • Real Estate and Construction
      • Tech News
    • Economy
      • Get Data
      • Macro-Economic News
      • Research Analysis
    • Business News
    • Financial Literacy
      • Career tips
      • Personal Finance
    • Lifestyle
      • Billionaire Watch
      • Profiles
    • Opinions
      • Blurb
      • Op-Eds

    © 2022 Nairametrics

    Social Media Auto Publish Powered By : XYZScripts.com